Biotechnology

Avid Bioservices Inc (NASDAQ: CDMO) Q4 2022 earnings call dated Jun. 29, 2022 Corporate Participants: Tim Brons -- Investor Relations Nicholas Green -- President…

Bio Path Holdings Inc (NASDAQ: BPTH) Q1 2022 earnings call dated May. 17, 2022 Corporate Participants: Will O'Connor -- Managing Director Peter…

Veru Inc.  (NASDAQ: VERU) Q2 2022 earnings call dated May. 12, 2022 Corporate Participants: Samuel Fisch -- Executive Director of IR and…

CATALYST PHARMACEUTICALS INC (NASDAQ: CPRX) Q1 2022 earnings call dated May. 11, 2022 Corporate Participants: Alicia Grande -- Vice President, Chief Financial…

Cara Therapeutics Inc.  (NASDAQ: CARA) Q1 2022 earnings call dated May. 09, 2022 Corporate Participants: Iris Francesconi -- Interim Head of Investor…

Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than-expected earnings and revenues for the first quarter of 2022. The…

ImmunoGen, Inc. (NASDAQ: IMGN) Q1 2022 earnings call dated May. 06, 2022 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications…

Biogen Inc. (NASDAQ: BIIB) is currently going through a difficult phase as the biotechnology firm’s main products face stiff competition…

Jazz Pharmaceuticals PLC  (NASDAQ: JAZZ) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Andrea N. Flynn -- Vice President, Head,…

Regeneron Pharmaceuticals Inc.  (NASDAQ: REGN) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Ryan Crowe -- Vice President of Investor…

Moderna Inc.  (NASDAQ: MRNA) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Lavina Talukdar -- Senior Vice President and Head…

Sage Therapeutics Inc.  (NASDAQ: SAGE) Q1 2022 earnings call dated May. 03, 2022 Corporate Participants: Helen Rubinstein -- Investor Relations Barry Greene -- Chief…

For Eli Lilly and Company (NYSE: LLY), 2021 was a fruitful year in terms of financial performance and product development.…

Biogen Inc. (NASDAQ: BIIB) reported first quarter 2022 earnings results today. Total revenue decreased 6% year-over-year to $2.53 billion. GAAP net…

Eli Lilly and Company (NYSE: LLY) has reported higher earnings and revenues for the first quarter of 2022. The numbers…

BioMarin Pharmaceutical Inc.  (NASDAQ: BMRN) Q1 2022 earnings call dated Apr. 27, 2022 Corporate Participants: Traci McCarty -- Vice President, Investor Relations…

Beyondspring, Inc. (NASDAQ: BYSI) Q4 2021 earnings call dated Apr. 14, 2022 Corporate Participants: Ashley Sierchio -- Investor Relations Lan Huang -- Co-founder, Chairman…

The IPO market is yet to fully recover from headwinds like the economic slowdown and Russia-Ukraine war. But activity is…

Trxade Health Inc (NASDAQ: MEDS) Monday reported a narrower net loss for the fourth quarter of 2021 as the pharmaceutical services…

Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX) Q4 2021 earnings call dated Mar. 17, 2022 Corporate Participants: Alicia Grande -- Vice President, Chief Financial…

After starting the year on a high note, the IPO market is currently going through a slow phase mainly due…